ÂÜÀòÂÒÂ×

Adam Wieschhaus is the current director at Ori Biotech. Adam has previously worked at Isolere Bio, Kytopen, Slingshot Biosciences, Torus Biosystems, Vestaron Corporation, Northpond Ventures, IsoPlexis (NASDAQ: ISO), Inflammatix, Inc., and Ori Biotech.

Adam Wieschhaus studied pharmacology at Tufts University School of Medicine and earned their Ph.D. from the University of Illinois College of Medicine. Adam also holds a B.S. in biochemistry and molecular biology from The University of Georgia. In addition, they are a Chartered Financial Analyst (CFA) and is certified by the Financial Industry Regulatory Authority (FINRA) in Series 7, 86, 87, and 63.